+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Head & Neck Cancer Diagnostics Market by Product Type (Instruments, Reagents & Consumables, Services), Technology (Flow Cytometry, Fluorescence In Situ Hybridization, Imaging Technology), End User, Application, Cancer Type - Global Forecast 2025-2030- Product Image
Head & Neck Cancer Diagnostics Market by Product Type (Instruments, Reagents & Consumables, Services), Technology (Flow Cytometry, Fluorescence In Situ Hybridization, Imaging Technology), End User, Application, Cancer Type - Global Forecast 2025-2030- Product Image
Sale

Head & Neck Cancer Diagnostics Market by Product Type (Instruments, Reagents & Consumables, Services), Technology (Flow Cytometry, Fluorescence In Situ Hybridization, Imaging Technology), End User, Application, Cancer Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5456878
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The head and neck cancer diagnostics market is transforming rapidly, reshaping the clinical and commercial landscape for healthcare providers, laboratories, and diagnostics innovators. Strategic investments and shifting global dynamics are compelling senior leaders to reassess market positioning and operational resilience as innovative technologies and increasing complexity drive new opportunities and risks.

Market Snapshot: Head & Neck Cancer Diagnostics Market Overview

The head and neck cancer diagnostics market grew from USD 2.03 billion in 2024 to USD 2.38 billion in 2025. It is expected to continue growing at a CAGR of 16.83%, reaching USD 5.17 billion by 2030. This growth is fueled by technological innovation, an increasing emphasis on early and precise detection, and evolving stakeholder collaboration across the diagnostic value chain.

Scope & Segmentation

  • Product Types: Instruments (including biopsy devices, imaging systems, molecular diagnostic platforms), reagents & consumables (such as immunoassay kits, polymerase chain reaction reagents, and sequencing reagents), and a diverse range of services (including contract research organization activities, data analysis, and equipment maintenance).
  • Technologies: Key diagnostic methods consist of flow cytometry, fluorescence in situ hybridization, a variety of imaging technologies (computed tomography, magnetic resonance imaging, positron emission tomography), immunoassays, next generation sequencing, and polymerase chain reaction approaches.
  • End Users: Main stakeholders include ambulatory surgical centers, cancer research institutes, diagnostic laboratories, and hospitals focused on multidisciplinary care and advanced workflow integration.
  • Applications: The report covers use in disease diagnosis, patient monitoring, risk prognosis, and screening for asymptomatic populations to facilitate early intervention.
  • Cancer Types: Detailed insights are provided for laryngeal, nasopharyngeal, oral, and thyroid cancers, each characterized by specific clinical demands and diagnostic requirements.
  • Regions: Analysis encompasses the Americas, Europe, Middle East & Africa, and Asia Pacific, offering perspectives on how local infrastructure, policy, and market maturity impact adoption and innovation.

Key Takeaways for Senior Decision-Makers

  • Technological advances are creating integrated diagnostic pathways where data from molecular assays, advanced imaging, and histopathology enable deeper clinical insights.
  • Collaborative partnerships between industry players, academic institutions, and clinical laboratories are expediting the introduction of innovative assays into mainstream practice and facilitating real-world feedback on product performance.
  • Shifts in regulatory guidance and clinical protocols are driving demand for evidence-based diagnostic approaches tailored to patient-specific biology and disease progression.
  • Diverse stakeholder needs—ranging from accelerated workflows in ambulatory centers to capacity scaling in hospitals—are shaping product development and service offerings.
  • Supply chain resilience and interoperability remain central concerns as organizations navigate uncertain policy landscapes and evolving procurement models.
  • Segment-specific challenges, such as the necessity for precision in laryngeal cancer diagnostics or the relevance of biomarker discovery in nasopharyngeal cancer, are shaping product and technology strategies.

Tariff Impact: Navigating US Trade Policy Changes

New trade tariffs implemented in the United States since 2025 have significantly shifted supply chain strategies for head and neck cancer diagnostics stakeholders. Additional import duties on overseas-manufactured instruments and reagents are prompting organizations to reconsider procurement and budgeting, while lengthened lead times and logistical adjustments are encouraging more robust regional sourcing and inventory management. As a result, industry participants are adapting manufacturing and distribution plans to ensure high-quality diagnostic service continuity despite ongoing cost pressures.

Methodology & Data Sources

This market analysis synthesized data from peer-reviewed journals, regulatory filings, and industry publications. In-depth interviews with oncologists, laboratory directors, and senior decision-makers informed qualitative insights, while data triangulation methods bolstered reliability. Subject matter experts validated the findings to ensure accuracy and actionable relevance.

Why This Report Matters

  • Provides an integrated overview of key markets, technologies, and stakeholder strategies to empower executive-level planning and competitive differentiation.
  • Delivers segmentation across product, technology, region, and end-user dimensions, highlighting actionable trends and emerging risks for investor and leadership teams.
  • Equips decision-makers with evidence-based recommendations to guide research investments and product portfolio realignment, enhancing resilience amid shifting regulatory and geographic forces.

Conclusion

This report offers strategic clarity for senior leaders navigating the evolving head and neck cancer diagnostics sector. The analysis supports evidence-based decisions to harness innovation and strengthen operational resilience in a dynamic clinical landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of circulating tumor DNA assays for real-time monitoring of head and neck cancers
5.2. Adoption of AI-powered imaging platforms to improve early detection accuracy in head and neck lesions
5.3. Expansion of multiplex immunohistochemistry panels to refine prognostic stratification in oropharyngeal carcinoma
5.4. Growth of companion diagnostic development targeting PD-1/PD-L1 therapies in head and neck squamous cell carcinoma patients
5.5. Utilization of liquid biopsy biomarkers to predict treatment response and recurrence in salivary gland malignancies
5.6. Emergence of point-of-care molecular testing devices for rapid screening in resource-limited head and neck cancer clinics
5.7. Surge in deep learning algorithms analyzing radiomics data for personalized management of nasopharyngeal carcinoma
5.8. Implementation of genomic sequencing panels for comprehensive mutation profiling in recurrent head and neck tumors
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Head & Neck Cancer Diagnostics Market, by Product Type
8.1. Introduction
8.2. Instruments
8.2.1. Biopsy Devices
8.2.2. Imaging Systems
8.2.3. Molecular Diagnostic Instruments
8.3. Reagents & Consumables
8.3.1. Immunoassay Kits
8.3.2. Polymerase Chain Reaction Reagents
8.3.3. Sequencing Reagents
8.4. Services
8.4.1. Contract Research Organization
8.4.2. Data Analysis Services
8.4.3. Maintenance & Support
9. Head & Neck Cancer Diagnostics Market, by Technology
9.1. Introduction
9.2. Flow Cytometry
9.3. Fluorescence In Situ Hybridization
9.4. Imaging Technology
9.4.1. Computed Tomography
9.4.2. Magnetic Resonance Imaging
9.4.3. Positron Emission Tomography
9.5. Immunoassay
9.6. Next Generation Sequencing
9.7. Polymerase Chain Reaction
10. Head & Neck Cancer Diagnostics Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Cancer Research Institutes
10.4. Diagnostic Laboratories
10.5. Hospitals
11. Head & Neck Cancer Diagnostics Market, by Application
11.1. Introduction
11.2. Diagnosis
11.3. Monitoring
11.4. Prognosis
11.5. Screening
12. Head & Neck Cancer Diagnostics Market, by Cancer Type
12.1. Introduction
12.2. Laryngeal Cancer
12.3. Nasopharyngeal Cancer
12.4. Oral Cancer
12.5. Thyroid Cancer
13. Americas Head & Neck Cancer Diagnostics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Head & Neck Cancer Diagnostics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Head & Neck Cancer Diagnostics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche Ltd
16.3.2. Abbott Laboratories
16.3.3. Thermo Fisher Scientific Inc.
16.3.4. Danaher Corporation
16.3.5. QIAGEN N.V.
16.3.6. Hologic, Inc.
16.3.7. bioMérieux SA
16.3.8. Becton, Dickinson and Company
16.3.9. PerkinElmer, Inc.
16.3.10. Agilent Technologies, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. HEAD & NECK CANCER DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. HEAD & NECK CANCER DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. HEAD & NECK CANCER DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. HEAD & NECK CANCER DIAGNOSTICS MARKET: RESEARCHAI
FIGURE 26. HEAD & NECK CANCER DIAGNOSTICS MARKET: RESEARCHSTATISTICS
FIGURE 27. HEAD & NECK CANCER DIAGNOSTICS MARKET: RESEARCHCONTACTS
FIGURE 28. HEAD & NECK CANCER DIAGNOSTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HEAD & NECK CANCER DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY SEQUENCING REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY SEQUENCING REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DATA ANALYSIS SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DATA ANALYSIS SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY MAINTENANCE & SUPPORT, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY MAINTENANCE & SUPPORT, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING TECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY CANCER RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY CANCER RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY PROGNOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY PROGNOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY LARYNGEAL CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY LARYNGEAL CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY NASOPHARYNGEAL CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY NASOPHARYNGEAL CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY ORAL CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY ORAL CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY THYROID CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY THYROID CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 133. CANADA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 134. CANADA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 135. CANADA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 136. CANADA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 137. CANADA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 138. CANADA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 139. CANADA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 140. CANADA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 141. CANADA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 142. CANADA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 143. CANADA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 144. CANADA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 145. CANADA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. CANADA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. CANADA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 148. CANADA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 149. CANADA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 150. CANADA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 151. MEXICO HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 152. MEXICO HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 153. MEXICO HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 154. MEXICO HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 155. MEXICO HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 156. MEXICO HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 157. MEXICO HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 158. MEXICO HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 159. MEXICO HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 160. MEXICO HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 161. MEXICO HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 162. MEXICO HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 163. MEXICO HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. MEXICO HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. MEXICO HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. MEXICO HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. MEXICO HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 168. MEXICO HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 243. GERMANY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 244. GERMANY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 245. GERMANY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 246. GERMANY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 247. GERMANY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 248. GERMANY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 249. GERMANY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 250. GERMANY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 251. GERMANY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 252. GERMANY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 253. GERMANY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 254. GERMANY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 255. GERMANY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. GERMANY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. GERMANY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. GERMANY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. GERMANY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 260. GERMANY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 261. FRANCE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 262. FRANCE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 263. FRANCE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 264. FRANCE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 265. FRANCE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 266. FRANCE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 267. FRANCE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 268. FRANCE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 269. FRANCE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 270. FRANCE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 271. FRANCE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 272. FRANCE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 273. FRANCE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. FRANCE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. FRANCE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 276. FRANCE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 277. FRANCE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 278. FRANCE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 281. RUSSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 282. RUSSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 283. RUSSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 284. RUSSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 285. RUSSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 286. RUSSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 297. ITALY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 298. ITALY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 299. ITALY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 300. ITALY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 301. ITALY HEAD & NECK CANCER DIAGNOSTI

Samples

Loading
LOADING...

Companies Mentioned

  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • QIAGEN N.V.
  • Hologic, Inc.
  • bioMérieux SA
  • Becton, Dickinson and Company
  • PerkinElmer, Inc.
  • Agilent Technologies, Inc.

Table Information

Report AttributeDetails
No. of Pages192
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.38 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.17 Billion
Compound Annual Growth Rate16.8%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Head and Neck Cancer Diagnostics - Global Strategic Business Report - Product Image

Head and Neck Cancer Diagnostics - Global Strategic Business Report

  • Report
  • 296 Pages
  • Global
From
Head and Neck Cancer Diagnostics Market Report 2025 - Product Image

Head and Neck Cancer Diagnostics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Head and Neck Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Head and Neck Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Thyroid Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Thyroid Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Brain Cancer Diagnostics Market by Technology (Genetic Testing, Imaging, Molecular Diagnostics), Product (Consumables & Reagents, Equipment, Services), Indication, Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Brain Cancer Diagnostics Market by Technology (Genetic Testing, Imaging, Molecular Diagnostics), Product (Consumables & Reagents, Equipment, Services), Indication, Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From

About the Head and Neck Cancer Diagnostics Market

Head and neck cancer diagnostics is a field of medical diagnostics that focuses on the detection and diagnosis of cancers of the head and neck. This includes cancers of the oral cavity, pharynx, larynx, sinuses, and salivary glands. Diagnostic tests used to detect head and neck cancer include imaging tests such as X-rays, CT scans, MRI scans, and PET scans, as well as biopsies and endoscopies. These tests are used to identify the location and extent of the cancer, as well as to determine the best course of treatment. Head and neck cancer diagnostics is an important part of the overall diagnostics market, as early detection and diagnosis of these cancers can lead to better outcomes for patients. Companies in this market include Siemens Healthineers, Philips Healthcare, GE Healthcare, Hologic, and FUJIFILM SonoSite. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.